The new ACR/EULAR remission criteria: Rationale for developing new criteria for remission

Rheumatology (United Kingdom)

Volumn 51, Issue SUPPL. 6, 2012, Pages

  Bykerk, Vivian P ^a,b   Massarotti, Elena M ^c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ACR EULAR remission criteria; DAS; DAS28; Radiographic progression; Rheumatoid arthritis; SDAI; Tender swollen joint counts

Indexed keywords

C REACTIVE PROTEIN; GOLIMUMAB; METHOTREXATE;

ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; EUROPEAN LEAGUE AGAINST RHEUMATISM REMISSION CRITERIA; FIBROMYALGIA; HUMAN; INFORMATION SCIENCE; JOINT SWELLING; LOGISTIC REGRESSION ANALYSIS; METHODOLOGY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PAIN ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SIMPLIFIED DISEASE ACTIVITY INDEX; SYNOVITIS; VALIDATION PROCESS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; DISEASE PROGRESSION; EUROPE; HUMANS; JOINTS; REMISSION INDUCTION; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84870861473     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes281     Document Type: Article

References (24)

1. Bykerk VP, Akhavan P, Hazlewood GS et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39:1559-82.
2. Saag KG, Teng GG, Patkar NM et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59: 762-84.
3. Smolen JS, Landewe R, Breedveld FC et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
4. Lillegraven S, Prince FH, Shadick NA et al. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis 2012;71:681-6.
5. Klarenbeek NB, van der Kooij SM, Guler-Yuksel M et al. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis 2011;70:315-9.
6. Katchamart W, Bombardier C. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis. J Rheumatol 2010;37: 1411-5.
7. Aletaha D, Landewe R, Karonitsch T et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum 2008;59:1371-7.
8. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
9. Prevoo ML, van Gestel AM, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996;35:1101-5.
10. Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 2004;43:1252-5.
11. Kuriya B, Arkema EV, Bykerk VP, Keystone EC. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission. Ann Rheum Dis 2010;69:1298-304.
12. Pincus T, Yazici Y, Bergman M, Maclean R, Harrington T. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best Pract Res Clin Rheumatol 2007;21: 789-804.
13. Makinen H, Kautiainen H, Hannonen P, Sokka T. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005;64:1410-3.
14. Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005;52:2625-36.
15. Felson DT, Smolen JS, Wells G et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70: 404-13.
16. Emery P, Keystone E, Fleischmann R. New provisional American College of Rhuematology/European League Against Rhuematism definition of remission criteria: results from 2 randomized controlled golimumab trials. Arthritis Rheum 2011;63:S874.
17. Shahouri SH, Michaud K, Mikuls TR et al. Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheum 2011;63:3204-15.
18. O'Dell JR, Mikuls TR. To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritis. Arthritis Rheum 2011;63:587-9.
19. Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 2004;31:695-700.
20. Kuriya B, Sun Y, Boire G et al. Canadian Early Arthritis Cohort. Remission in early rheumatoid arthritis-a comparison of new ACR/EULAR remission criteria to established criteria. J Rheumatol 2012;39:1155-8.
21. van der Woude D, Young A, Jayakumar K et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 2009;60:2262-71.
22. Bykerk VP. Rheumatoid arthritis: 2011 remission criteria are a new benchmark for RA therapy. Nat Rev Rheumatol 2011;7:317-8.
23. Kapral T, Dernoschni F, Machold KP et al. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? Arthritis Res Ther 2007;9:R72.
24. Saleem B, Brown AK, Keen H et al. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments. Ann Rheum Dis 2011;70:792-8.